Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma

Published:2020-04-19 Issue:6 Volume:99 Page:1251-1255
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Migkou Magdalini,Avivi Irit,Gavriatopoulou Maria,Cohen Yael C.,Fotiou Despina,Kanellias Nikolaos,Ziogas Dimitrios,Eleutherakis-Papaiakovou Evangelos,Terpos Evangelos,Roussou Maria,Kastritis Efstathios,Dimopoulos Meletios A.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-03984-w.pdf

Reference23 articles.

1. Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Blade J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, Miguel JS, Avet-Loiseau H (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328–e346. https://doi.org/10.1016/S1470-2045(16)30206-6

2. Turesson I, Grubb A (1978) Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature. Acta Med Scand 204(6):445–451

3. Joyner MV, Cassuto JP, Dujardin P, Schneider M, Ziegler G, Euller L, Masseyeff R (1979) Non-excretory multiple myeloma. Br J Haematol 43(4):559–566

4. Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102(5):1115–1123

5. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR (2001) Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 97(9):2900–2902

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in “real-world” study: Experiences of the Polish Myeloma Group;Advances in Clinical and Experimental Medicine;2024-08-29

2. Serum B-Cell Maturation Antigen Reflects Disease Status in a Patient Who Developed Nonsecretory Multiple Myeloma: A Case Report;Case Reports in Oncology;2024-07-12

3. Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies;Antibodies;2024-03-11

4. Non-Secretory Multiple Myeloma: A New Observation and Review of the Literature;Cureus;2024-02-19

5. A case report: Nonsecretory multiple myeloma presenting with bone pain;Medicine;2024-02-02